SOSA and Parallel in silico Screening: Merging Medicinal Chemistry Tradition with a Modern Computational Approach
Thierry Langer, CEO, Prestwick Chemicals, speaking at MedChem Europe 2009
Prediction of Drug-Drug Interactions Caused by Metabolism-Based Inhibition of Cytochrome P450 Using a Mechanistic Static Model: The Weak & Missing Links?
Olivier Barberan, Director of Product Development, AUREUS-Pharma, speaking at ADMET Europe 2009
Utilizing GC and GCxGC Coupled with Time-of-Flight Mass Spectroscopy (TOMFS) for the Analysis of Metabolomic Samples
Mark Libardoni, Technical Director - Life Science and Chemical Analysis Centre, LECO Corporation, speaking at Advances in Metabolic Profiling
Alterations in Cardiolipin Profile Link Diabetic Cardiomyopathy and Mitochondrial Dysfunction in Murine Models of Diabetes: A Shotgun Lipidomics Study
Xianlin Han, Washington University, speaking at Advances in Metabolic Profiling 2007
Moving Metabolic Profiling from Mouse to Human and from Laboratory into the Clinic
Agnieszka Lichanska, Lecturer, University of Queensland, speaking at Advances in Metabolic Profiling 2007
Intergration of Isotopomer-based Metabolomics with Functional Genomics
Teresa Fan, Assistant Professor, University of Louisville, speaking at Advances in Metabolic Profiling 2007
Metabolomics Strategy to Identify Tissue Specific Drug Effects
Matej Orešic, Chief Research Scientist, VTT Technical Research Centre, speaking at the European Biomarker Summit, 2007
Novel Biomarker Discovery Using Metabolomics
Felice de Jong, Director, Metabolon Inc. speaking at the European Biomarkers Summit 2006.
LC/MS/MS Solutions for Targeted and Non-Targeted Small Molecule and Protein Biomarker Discovery, Verification and Validation
Henri Snijders, European Marketing Manager Small Molecules, Applied Biosystems speaking at the European Biomarkers Summit 2006.